Updates matching "Access to Biomarker Testing"

Cancer Advocates Urge Elected Officials to Ensure Connecticuters Have Better Access to Personalized Care

Cancer Advocates Urge the Senate to Do Better Than the House to Ensure West Virginians Have Better Access to Personalized Care.

Cancer Advocates Urge the Governor to Quickly Sign This Legislation Ensuring Hoosiers Have Better Access to Personalized Care.

SANTA FE, NEW MEX. – February 22, 2024 – State Representative Joy Garratt was honored with the ‘Legislative Champion Award’ by the American Cancer Society Cancer Action Network (ACS CAN) during a luncheon, Thursday. This award is the highest honor given by the organization. Garratt was recognized for her leading role in expanding access to biomarker testing in New Mexico. She served as a lead sponsor for HB 73 during the 2023 legislative session.

A new paper released today in the Journal of Clinical Oncology finds that while incorporating pharmacogenomic (PGx) testing into cancer care can help improve patient outcomes, barriers to PGx testing, discovery, and implementation are impacting its adoption and creating disparities that impact diverse populations.

INDIANAPOLIS, IN – This afternoon, the Indiana Senate passed Senate Bill 273, which would ensure biomarker testing, a game changer in the fight against cancer and an essential step in accessing precision medicine treatments, is covered by more insurance plans in the Hoosier state. The following is a statement from

Those who traveled to the Capitol will continue to work with legislators to change that and urge them to get biomarker access expanded in 2025. Eventual passage of this legislation will make sure more residents have insurance coverage that allows for easy access to precision medicine.

HARRISBURG, PA – FEBRUARY 5, 2024 – With the 2024 legislative session underway and Governor Shapiro’s budget address set for tomorrow, here is a statement from Donna Greco, American Cancer Society Cancer Action Network (ACS CAN) Pennsylvania Government Relations Director: “As Pennsylvania lawmakers return to the 2024 legislative session, ACS

Cancer patients, survivors, their families and caregivers from throughout Washington gathered at the Capitol on Monday to ask legislators to support House Bill 1450, which would have expanded insurance coverage of biomarker testing and made sure as many state residents as possible have access to this technology. They were disappointed to learn that the bill did not advance through House Appropriations and so instead turned their efforts and advocacy to the 2025 session.